1-6 of 6
Youcef Chelgoum
Close
Sort by
Journal Articles

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Franck-Emmanuel Nicolini, MD PhD, Hélène Labussière, MD, Olivier Hequet, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5720.
https://doi.org/10.1182/blood-2018-99-118206
Published: 2018
Journal Articles

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Mauricette Michallet, MD PhD, Mohamad Sobh, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Fiorenza Barraco, MD, Helene Labussiere-Wallet, MD, Franck Emmanuel Nicolini, MD PhD, Olivier Hequet, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4504.
https://doi.org/10.1182/blood.V130.Suppl_1.4504.4504
Published: 2017
Journal Articles

Prolonged Survival without Complete Remission (CR) In AML Patients (Pts) Treated with Azacitidine (AZA)

Raphael Itzykson, Sylvain Thepot, Odile Beyne-Rauzy, Bruno Quesnel, Shanti Ame, MD, Pascal Turlure, Stephanie Harel, Anne Marfaing-Koka, Youcef Chelgoum, Aspasia Stamatoullas, Madalina Uzunov, Norbert Ifrah, Herve Dombret, MD, PhD, Lionel Ades, CL Beach, PharmD, Arlene S. Swern, PhD, Claude Gardin, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 2183.
https://doi.org/10.1182/blood.V116.21.2183.2183
Published: 2010
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Nicole Raus, Daniela Revesz, MD, Jacques Troncy, MD, Youcef Chelgoum, MD, Jean-Paul Bourgeot, Philippe Dubost, Olivier Hequet, MD PhD, Franck E. Nicolini, MD PhD
Journal: Blood
Blood (2007) 110 (11): 3048.
https://doi.org/10.1182/blood.V110.11.3048.3048
Published: 2007
Journal Articles

Impact of Chimerism and Other Transplant Variables on Allogeneic Transplant Outcome after Reduced Intensity Conditioning (RIC) Regimens.

Veronica Ortiz Corbella, MD, Quoc-Hung Lê, MD, Franck E. Nicolini, MD, PhD, Anne Thiébaut, MD, Xavier Thomas, MD, PhD, Youcef Chelgoum, MD, Sophie Ducastelle, MD, Isabelle Mollet, PhD, Valérie Dubois, MD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5258.
https://doi.org/10.1182/blood.V108.11.5258.5258
Published: 2006